老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

239.77
-25.1500-9.49%
盤後：239.770.00000.00%19:49 EDT
成交量：296.13萬
成交額：6.98億
市值：158.70億
市盈率：18.50
高：257.53
開：257.17
低：228.56
收：264.92
52周最高：282.15
52周最低：186.05
股本：6,618.99萬
流通股本：6,553.95萬
量比：5.88
換手率：4.52%
股息：- -
股息率：- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率：118.78%
總資產收益率：9.58%
市淨率：9.57
市盈率(LYR):-54.28

資料載入中...

總覽公司新聞資訊公告
2020/12/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/22

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/08

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多